Specialty Pharmacy

Pharmacists don't have to learn American Sign Language to effectively communicate with deaf and hard-of-hearing patients, but they do need to improve their knowledge, attitudes, and comfort levels.

Despite increases in liver cirrhosis hospitalizations over the years, the cirrhotic inpatient death rate has dropped 41%.

Long term implications result when patients stop taking disease-modifying drugs.

An antiviral and anti-cancer drug combination was 100% effective in preclinical trials.

Top stories of the week on Specialty Pharmacy Times from April 20 to April 24.

Wiskott-Aldrich treatment shows robust clinical effect.

Re-engineering antibodies allows them to selectively kill tumors.

COPD patients must clear major hurdles before and after initiating nebulizer use.

Catamaran chief medical officer discusses various trends that will impact specialty medications into the future.

Regulating PD-L1 protein that helps cancer evade immune system suggests new therapeutic approach.

Patients should be counseled that there is no safe level of alcohol consumption.

The FDA today approved a second-line treatment for metastatic colorectal cancer.

The FDA has awarded Breakthrough Therapy status to crizotinib (Xalkori) for ROS1-positive non-small cell lung cancer.

Novel pathway regulating immune cell movement may help eliminate debilitating effects of several serious diseases.

Pushing treatment with natalizumab from 4 weeks up to 8 weeks shows promising results.

Researchers determine mechanism for poor survival rates in African American patients with estrogen-receptor positive breast cancer.

Pharmacists in North Dakota came closer to attaining provider status when state Gov. Jack Dalrymple recently signed 4 laws recognizing pharmacists as providers.

Mild exercise found to improve fatigue and depression.

Medication also used in treatment of Crohn's disease effective at blocking pathways.

Mild cognitive impairment can set in prior to the start of therapy.

Phenytoin helps to reduce damage to the nerve fiber.

Itraconazole shows some promise in treatment of metastatic prostate cancer.

The FDA has granted Orphan Drug Designation to AstraZeneca's selumetinib.

Orphan drugs and breakthrough therapies last year comprised the highest number of new medications approved since 2001.

Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses how specialty pharmacists can help manage difficult lung cancer therapy.

Mortality gap in cancer deaths among African Americans and Caucasians may eventually disappear.

Treatment found to improve several measures of disease activity and quality of life in patients with Behçet's disease.

Study suggests substances in synthetic marijuana may damage human cell DNA.